成都科岭源医药技术有限公司 Chengdu SciMount Pharmatech Co. Ltd.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome 2020-05-14 18:00
1